v3.25.4
Stockholders' Equity and Equity Incentive Plans (Tables)
 12 Months Ended
Jan. 31, 2026
Equity [Abstract]  
Schedule of Stock by Class Reserved for Future Issuance
We have the following shares of Class A common stock reserved for future issuance:
 
As of January 31,
 20262025
Stock options outstanding1,542,753 2,394,918 
RSUs outstanding20,106,305 23,870,513 
ESPP purchase rights outstanding 1,293,529 2,311,567 
Remaining shares available for future issuance under the 2011 and 2019 plan66,954,929 56,022,675 
Remaining shares available for future issuance under the ESPP20,664,260 18,807,595 
Total shares of Class A common stock reserved110,561,776 103,407,268 
Schedule of Stock Option Activity Under Equity Incentive Plan
A summary of stock option activity under our equity incentive plan and related information is as follows:
Stock Options
 Outstanding
Stock
Options		Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
 (in thousands, except share, life and per share data)
Outstanding as of January 31, 20252,394,918 $9.02 2.6$187,284 
Exercised(842,567)$2.95 $66,978 
Canceled/forfeited/expired(9,598)$94.87 
Outstanding and Exercisable as of January 31, 20261,542,753 $11.81 2.2$124,080 
Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan
A summary of RSU activity under our equity incentive plan and related information is as follows:
RSUs
Unvested
RSUs		Weighted-Average
Grant Date Fair Value Per Share
Unvested as of January 31, 202523,870,513 $73.48 
Granted10,695,967 $80.21 
Vested(11,309,015)$76.45 
Forfeited(3,151,160)$72.94 
Unvested as of January 31, 202620,106,305 $75.51 
Schedule of Assumptions for Estimating Fair Value of ESPP Purchase Rights
We estimated the fair value of ESPP purchase rights using a Black-Scholes option-pricing model with the following assumptions:
Year Ended January 31,
202620252024
Expected term (years)
0.5 - 2.0
0.5 - 2.0
0.5 - 2.0
Expected volatility
31.2% - 33.0%
28.4% - 43.3%
30.0% - 57.6%
Risk-free interest rate
3.5% - 4.3%
4.2% - 5.4%
4.6% - 5.4%
Expected dividend yield———
Schedule of Stock-based Compensation Expense
The stock-based compensation expense by line item in the accompanying consolidated statements of operations is summarized as follows:
Year Ended January 31,
202620252024
(in thousands)
Cost of revenue$96,273 $124,561 $143,798 
Research and development287,172 333,767 336,309 
Sales and marketing254,976 319,631 381,298 
General and administrative122,355 153,350 195,756 
Total stock-based compensation expense760,776 931,309 1,057,161 
Benefit from income taxes(143,661)(176,463)(197,068)
Total stock-based compensation expense recorded to net income$617,115 $754,846 $860,093